You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
19 January 2021 - - The Center for Drug Evaluation of China National Medical Products Administration has approved EdiGene, Inc's Investigational New Drug application for ET-01, an investigational CRISPR/Cas 9 gene-editing therapy for patients wi...
19 January 2021 - - US-based biotechnology company Vera Therapeutics, Inc has launched backed by USD 80m Series C financing led by Abingworth LLP, the company said.
Other investors included Sofinnova Investments, Longitude Capi...
Other investors included Sofinnova Investments, Longitude Capi...
19 January 2021 - - France-based biotechnology company Transgene (Euronext Paris: TNG) has received approval from the French National Agency for the Safety of Medicines and Health Products to proceed with a Phase I/IIa study of the novel oncolytic&nb...
19 January 2021 - - UK-based integrated cell and gene therapy company Ixaka Ltd has launched, the company said.
The company's shareholders have funded the business with over GBP 40m in financing.
Previously Rexgenero Lt...
The company's shareholders have funded the business with over GBP 40m in financing.
Previously Rexgenero Lt...
19 January 2021 - - UK-based digital asset tracking and monitoring provider Everyware Ltd and enterprise-grade distributed ledger provider Hedera Hashgraph are working with an initial group of National Health Service facilities to moni...
19 January 2021 - - British-Swedish pharmaceutical and biopharmaceutical company AstraZeneca (OTC: AZNCF) and Japan-based pharmaceutical company Daiichi Sankyo Company, Ltd's (OTC: DSKYF) Enhertu (fam-trastuzumab deruxtecan-nxki) has been approv...
19 January 2021 - - US-based medical diagnostic products provider Cue Health Inc's molecular, point-of-care COVID-19 Tests are being distributed to five additional states, including Colorado, Minnesota, Pennsylvania, Rho...